Furthermore, we observed prolonged survival in KNS-42 GBM-bearing mice treated with RCAN1-422-32-reactive TCR-T cells compared with mock-treated or PBS-treated mice (Fig. 6E). The gene discussed is RCAN1; the disease is glioblastoma.